HiFiBiO Therapeutics discloses its newly formed Scientific Advisory Board
– USA, MA / CHINA, Shanghai / FRANCE, Paris – HiFiBiO Therapeutics, a pioneer in innovative biotherapeutics with a unique single-cell analytics platform for extensive immune profiling, today announced the formation of a Scientific Advisory Board comprised of experts in immunology, oncology and cell therapy, as well as drug discovery and development.…